InvestorsHub Logo
Followers 63
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: masterlongevity post# 757

Thursday, 04/26/2012 11:59:42 PM

Thursday, April 26, 2012 11:59:42 PM

Post# of 890
ML - your statement here -

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=74908449

"how do you spend $50M in RnD in Q1 with absolutely ZERO drugs in clinical development?"

To begin with, you are unaware that Elan has Tysabri in a major p3 trial for SPMS? http://clinicaltrials.gov/ct2/show/NCT01416181?term=natalizumab&rank=1

And here are several more trials - http://www.elan.com/rd/clinical_trials/autoimmune_diseases.asp